financetom
Business
financetom
/
Business
/
GE Vernova Expands Wind Power Footprint With New German Project
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GE Vernova Expands Wind Power Footprint With New German Project
Sep 16, 2025 6:43 AM

GE Vernova Inc. ( GEV ) said Tuesday it will supply eight 6MW-164m turbines to Prokon Regenerative Energien eG to repower a wind farm in the Fleetmark community of Sachsen-Anhalt, Germany. The machines will be built at GE Vernova’s Salzbergen facility.

The order was booked in the second quarter of 2025 and underscores the company’s “Workhorse Product Strategy” for onshore wind.

Gilan Sabatier, chief commercial officer for GE Vernova’s onshore wind business, said repowering sites increases generation from existing wind farms while helping Germany meet renewable energy targets. He added that the company’s Salzbergen operations put it in a strong position to serve domestic demand.

Also Read: GE Vernova Stock Climbs On Dublin Bay Power Plant Modernization Deal

Katharina Beyer, Prokon board member for project development, said the cooperative again selected GE Vernova ( GEV ) turbines after previous projects proved reliable. “For us, what matters is not only the technology itself but also a professional and constructive collaboration throughout the entire planning and construction process,” Beyer said.

Germany installed about 3.2 gigawatts of onshore wind in 2024. The government aims for 80% of electricity to come from renewable sources by 2030, and repowering older sites is central to that strategy.

The Fleetmark deal follows another milestone earlier this month. On September 8, GE Vernova ( GEV ) said it will partner with Ireland’s Electricity Supply Board on a major life extension and modernization project at the Dublin Bay power plant. That upgrade, which includes its GT26 High Efficiency package, is expected to add nearly 30 megawatts of power, enough to supply about 30,000 Irish homes annually, while also enabling the plant to integrate hydrogen blends in the future.

Price Action: GEV shares were trading higher by 0.21% to $629.96 premarket at last check Tuesday.

Read Next:

Bloom Energy Is Not Jim Cramer’s ‘Cup Of Tea,’ But It’s Going Up

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved